Literature DB >> 12069104

Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report.

Ludivine Walter1, Hideto Miyoshi, Xavier Leverve, Paolo Bernard, Eric Fontaine.   

Abstract

The permeability transition pore (PTP) is a mitochondrial inner membrane Ca2+-sensitive channel that plays a key role in different models of cell death. In a series of recent studies we have shown that the PTP is modulated by quinones, and we have identified three functional classes: (i) PTP inhibitors; (ii) PTP inducers; and (iii) PTP-inactive quinones that compete with both inhibitors and inducers. Here, we review our current understanding of pore regulation by quinones, and present the results obtained with a new series of structural variants. Based on the effects of the compounds studied so far, we confirm that minor structural changes profoundly modify the effects of quinones on the PTP. On the other hand, quinones with very different structural features may have qualitatively similar effects on the PTP. Taken together, these results support our original proposal that quinones affect the PTP through a common binding site whose occupancy modulates its open-closed transitions, possibly through secondary changes of the Ca2+-binding affinity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069104     DOI: 10.1080/10715760290021252

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  26 in total

Review 1.  Prerequisites for ubiquinone analogs to prevent mitochondrial permeability transition-induced cell death.

Authors:  Julie Belliere; Flavien Devun; Cécile Cottet-Rousselle; Cécile Batandier; Xavier Leverve; Eric Fontaine
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

2.  Xin Fu Kang oral liquid inhibits excessive myocardial mitophagy in a rat model of advanced heart failure.

Authors:  Zhiling Qiu; Yuanhui Hu; Yanting Geng; Huaqin Wu; Rongqiang Bo; Jingjing Shi; Jiuchong Wang; Huan Wang
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

Review 3.  Coenzyme Q and mitochondrial disease.

Authors:  Catarina M Quinzii; Michio Hirano
Journal:  Dev Disabil Res Rev       Date:  2010

4.  Effects of decreasing mitochondrial volume on the regulation of the permeability transition pore.

Authors:  Véronique Nogueira; Anne Devin; Ludivine Walter; Michel Rigoulet; Xavier Leverve; Eric Fontaine
Journal:  J Bioenerg Biomembr       Date:  2005-02       Impact factor: 2.945

5.  Expression of the human atypical kinase ADCK3 rescues coenzyme Q biosynthesis and phosphorylation of Coq polypeptides in yeast coq8 mutants.

Authors:  Letian X Xie; Edward J Hsieh; Shota Watanabe; Christopher M Allan; Jia Y Chen; UyenPhuong C Tran; Catherine F Clarke
Journal:  Biochim Biophys Acta       Date:  2011-02-04

6.  The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.

Authors:  Anna W C Leung; Pinadda Varanyuwatana; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

Review 7.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 8.  Mitochondria and reperfusion injury of the heart--a holey death but not beyond salvation.

Authors:  Andrew P Halestrap
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

9.  Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation.

Authors:  Emy Basso; Valeria Petronilli; Michael A Forte; Paolo Bernardi
Journal:  J Biol Chem       Date:  2008-08-06       Impact factor: 5.157

10.  Long-chain ceramide is a potent inhibitor of the mitochondrial permeability transition pore.

Authors:  Sergei A Novgorodov; Tatyana I Gudz; Lina M Obeid
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.